Connection

W. Garvey to Matrix Metalloproteinases

Back to Details
This is a "connection" page, showing publications W. Garvey has written about Matrix Metalloproteinases.
W. Garvey
Connection Strength
0.062
Matrix Metalloproteinases
  1. Administration of pioglitazone in low-density lipoprotein receptor-deficient mice inhibits lesion progression and matrix metalloproteinase expression in advanced atherosclerotic plaques. J Cardiovasc Pharmacol. 2006 Nov; 48(5):212-22.
    View in: PubMed
    Score: 0.062
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.